| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |